| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |